HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anti-AIDS agents 49. Synthesis, anti-HIV, and anti-fusion activities of IC9564 analogues based on betulinic acid.

Abstract
The betulinic acid derivative IC9564 inhibits human immunodeficiency virus (HIV)-1 entry. Among a series of IC9564 derivatives, 5 and 20 were the most promising compounds against HIV infection with EC(50) values of 0.33 and 0.46 microM, respectively. Both compounds inhibited syncytium formation with EC(50) values of 0.40 and 0.33 microM, respectively. The comparable EC(50) values in the two assays suggested that these compounds are fusion inhibitors. The structure-activity relationship data also indicated that a double bond in IC9564 can be eliminated and the statine moiety can be replaced with L-leucine while retaining anti-HIV activity.
AuthorsI-Chen Sun, Chin-Ho Chen, Yoshiki Kashiwada, Jiu-Hong Wu, Hui-Kang Wang, Kuo-Hsiung Lee
JournalJournal of medicinal chemistry (J Med Chem) Vol. 45 Issue 19 Pg. 4271-5 (Sep 12 2002) ISSN: 0022-2623 [Print] United States
PMID12213068 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Amides
  • Anti-HIV Agents
  • HIV Fusion Inhibitors
  • IC9564
  • N'-(N-(3-hydroxybetulin-28-oyl)-11-aminoundecanoyl)leucine
  • N'-(N-(3-hydroxydihydrobetulin28-oyl)-8-aminooctanoyl)-4-amino-3-hydroxy-6-methylheptanoic acid
  • Pentacyclic Triterpenes
  • Triterpenes
  • Leucine
  • Betulinic Acid
Topics
  • Amides (chemical synthesis, chemistry, pharmacology)
  • Animals
  • Anti-HIV Agents (chemical synthesis, chemistry, pharmacology)
  • COS Cells
  • Chlorocebus aethiops
  • HIV Fusion Inhibitors (chemical synthesis, chemistry, pharmacology)
  • HIV-1
  • Leucine (analogs & derivatives, chemical synthesis, chemistry, pharmacology)
  • Membrane Fusion (drug effects)
  • Pentacyclic Triterpenes
  • Structure-Activity Relationship
  • Triterpenes (chemical synthesis, chemistry, pharmacology)
  • Betulinic Acid

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: